Study: Statins may protect hep C patients from liver cancer

03/22/2013 | Reuters

The use of cholesterol-lowering statin drugs among patients with chronic hepatitis C was associated with a decreased risk of liver cancer, according to a study of around 261,000 patients in Taiwan. The reductions were modest, but the findings could address possible concerns about prescribing statins to patients with liver disease, a U.S. researcher commented. The study appeared in the Journal of Clinical Oncology.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR